Samalin Investment Counsel, LLC Aveo Pharmaceuticals, Inc. Transaction History

Samalin Investment Counsel, LLC

  • $222 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$3.51 - $6.67 $702 - $1,334
-200 Closed
0 $0
Q2 2021

Aug 12, 2021
BUY
$6.21 - $7.45 $1,242 - $1,490
200 New
200 $1,000
Q1 2021

May 11, 2021
SELL
$5.97 - $15.28 $1,194 - $3,056
-200 Closed
0 $0
Q3 2020

Nov 10, 2020
BUY
$4.16 - $6.26 $832 - $1,252
200 New
200 $1,000

Others Institutions Holding AVEO

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0
View Full List

About AVEO PHARMACEUTICALS, INC.

AVEO Quotes by TradingView
  • Ticker AVEO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 34,676,000
  • Description
  • AVEO Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing and commercializing medicines for cancer patients. It markets its lead candidate, FOTIVDA, an oral, once-daily, vascular endothelial growth factor receptor tyrosine kinase inhibitor, which is used for the treatment of renal cell carcinoma (RCC); and tivozanib for the ...
More about AVEO
Track This Portfolio

Track Samalin Investment Counsel, LLC Portfolio

Follow Samalin Investment Counsel, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Samalin Investment Counsel, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Samalin Investment Counsel, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email